Diskussionsleiter: U. Laufs (Homburg/Saar)
| (P1060) | Dysregulation of the neutral amino acid carrier SLC1A5 decreases glutamine levels in the failing myocardium and induces autophagy | |
| P. Kennel, X. Liao, R. Ji, X. Zhang, E. Castillero, D. Brunjes, H. Takayama, Y. Naka, I. George, D. Mancini, C. Schulze (New York, US; Jena) | ||
| (P1061) | Cardiac specific overexpression of desmocollin-2 (DSC2) leads to severe fibrotic cardiomyopathy in mice | |
| A. Brodehl, L. Garnett, K. Martens, C. Diao, A. Nygren, D. D. Belke, B. Gerull (Calgary, CA; Würzburg) | ||
| (P1062) | Cardiac function remains impaired despite reversible cardiac fibrosis after resolved viral myocarditis in mice | |
| D. Lindner, P. M. Becher, F. Gotzhein, K. Klingel, S. Blankenberg, D. Westermann (Hamburg, Tübingen) | ||
| (P1063) | Impaired cardiac function in MMP13 knock out mice | |
| D. Lindner, P. M. Becher, S. Hinrichs, S. Lämmle, F. Gotzhein, V. Lang, A. El-Armouche, S. Blankenberg, D. Westermann (Hamburg, Dresden) | ||
| (P1064) | A genome wide approach identifies Histone Deacetylase 4 (HDAC4) as a central epigenetic modifier in cardimoyocytes | |
| D. Finke, L. H. Lehmann, V. Sramek, J. Haas, B. Meder, H. A. Katus, E. Furlong, J. Backs (Heidelberg) | ||
| (P1065) | AAV Serotype Efficacy for Anterograde Interventional Cardiac Gene Therapy in a Pre-Clinical Large Animal Model | |
| F. Woitek, V. Adams, G. C. Schuler, F. Recchia, A. Linke (Leipzig; Phialdephia, US) |